GlycoMimetics (GLYC) Tops Q1 EPS by 3c; Reports Cash and Cash Equivalents of $76.5M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts GLYC Hot Sheet
Join SI Premium – FREE
GlycoMimetics (NASDAQ: GLYC) reported Q1 EPS of ($0.28), $0.03 better than the analyst estimate of ($0.31). Cash and cash equivalents at March 31, 2022 were $76.5 million.
For earnings history and earnings-related data on GlycoMimetics (GLYC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Top restaurant stocks to watch, according to Raymond James
- Accenture shares fall on insider sales and analyst downgrade
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
